Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Ordinary shares
-
Shares outstanding
-
49,942,911
-
Total 13F shares
-
168,168
-
Share change
-
+79,495
-
Total reported value
-
$11,489,238
-
Price per share
-
$68.32
-
Number of holders
-
3
-
Value change
-
+$5,431,098
-
Number of buys
-
2
Institutional Holders of Immunocore Holdings plc - Ordinary shares (IMCR) as of Q4 2023
As of 31 Dec 2023,
Immunocore Holdings plc - Ordinary shares (IMCR) was held by
3 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
168,168 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, WELLINGTON MANAGEMENT GROUP LLP, PRICE T ROWE ASSOCIATES INC /MD/, Rock Springs Capital Management LP, BAKER BROS. ADVISORS LP, FMR LLC, Paradigm Biocapital Advisors LP, Bellevue Group AG, GENERAL ATLANTIC, L.P., and MORGAN STANLEY.
This page lists
133
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.